Plandai Biotechnolog
Plandai Biotechnology to Use "Trojan Horse" to Make Highly Bioavailable Products Even Stronger
20. Januar 2015 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - January 20, 2015) - Plandaí Biotechnology (OTCQB: PLPL) proved in a bioavailability study performed at North West University in South Africa, that its green tea Phytofare®...
Plandai Biotechnolog
Plandai Biotechnology's Medical Marijuana Subsidiary Will Introduce Marijuana Industry to Unzipping Molecules
15. Januar 2014 09:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jan 15, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) could hold the key to making what is a miracle drug for some, into an even more powerful miracle drug for...
Plandai Biotechnolog
Plandai Biotechnology Benefits From Changes in Medical Marijuana Landscape in the U.S.
08. Januar 2014 09:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jan 8, 2014) - Another election year has arrived, and Plandai Biotechnology (OTCQB: PLPL) expects to benefit from both the growing number of states allowing medical...
Plandai Biotechnolog
Plandai Biotechnology's CEO Discusses Direction of Medical Marijuana Subsidiary
12. Dezember 2013 08:45 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Dec 12, 2013) -  Plandaí Biotechnology's (OTCQB: PLPL) subsidiary, Cannabis Biosciences, Inc., will be developing and testing a botanical extract derived from...
New Report Shows Pla
New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
19. November 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Late last week the International Diabetes Federation (IDF) released a report filled with some staggering statistics in the fight against diabetes....
Plandai Biotechnolog
Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
14. November 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 14, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) and its subsidiary, Cannabis Biosciences, Inc., received a strong validation for their move into medical...
Plandai Biotechnolog
Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract
30. Oktober 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Involved in Numerous Clinical Trials as Company Prepares Products for Market
03. Oktober 2013 09:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has several clinical trials already underway, and a host of others scheduled to commence in the company...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
02. Oktober 2013 08:45 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces New Extract in Its Ongoing Fight Against Malaria
01. Oktober 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 1, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...